Insulet
PODD
#1061
Rank
C$23.84 B
Marketcap
$339.49
Share price
-6.58%
Change (1 day)
52.27%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): C$0.47 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.07 Billion. , an increase over its 2023 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 C$0.48 B36.72%
2023 C$0.35 B481.9%
2022 C$60.99 M-45.24%
2021 C$0.11 B43.35%
2020 C$77.69 M18.51%
2019 C$65.56 M41.16%
2018 C$46.44 M-711.95%
2017 -C$7.59 Million-56.85%
2016 -C$17.6 Million-79.31%
2015 -C$85.04 Million63.85%
2014 -C$51.9 Million31.04%
2013 -C$39.61 Million-21.96%
2012 -C$50.76 Million
2010 -C$48.41 Million-42.38%
2009 -C$84.01 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$76.2 Million209.75%
2006 -C$24.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$57.35 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.14 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.03 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.68 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.92 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.46 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$17.94 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA